The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance
Open Access
- 1 January 2024
- journal article
- review article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Abstract
Globally, hepatic cancer ranks fourth in terms of cancer-related mortality and is the sixth most frequent kind of cancer. Around 80% of liver cancers are hepatocellular carcinomas (HCC), which are the leading cause of cancer death. It is well known that HCC may develop resistance to the available chemotherapy treatments very fast. One of the biggest obstacles in providing cancer patients with appropriate care is drug resistance. According to reports, more than 90% of cancer-specific fatalities are caused by treatment resistance. By binding to the 3'-untranslated region of target messenger RNAs (mRNAs), microRNAs (miRNAs), a group of noncoding RNAs which are around 17 to 25 nucleotides long, regulate target gene expression. Moreover, they play role in the control of signaling pathways, cell proliferation, and cell death. As a result, miRNAs play an important role in the microenvironment of HCC by changing immune phenotypes, hypoxic conditions, and acidification, as well as angiogenesis and extracellular matrix components. Moreover, changes in miRNA levels in HCC can effectively resist cancer cells to chemotherapy by affecting various cellular processes such as autophagy, apoptosis, and membrane transporter activity. In the current work, we narratively reviewed the role of miRNAs in HCC, with a special focus on tumor microenvironment and drug resistance.Keywords
This publication has 212 references indexed in Scilit:
- Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1Science, 2003
- ApoptosisCell, 2002
- Inflammation and cancer: back to Virchow?The Lancet, 2001
- Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinomaGut, 2001
- Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.1998
- Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.1997
- Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growthProceedings of the National Academy of Sciences, 1997
- A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).1994
- Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.Proceedings of the National Academy of Sciences, 1993
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992